Natural SEL1L variants rescue a model of NGLY1 deficiency and modify ERAD function and proteasome sensitivity.
N-glycanase 1 (NGLY1) deficiency is an ultra-rare disease caused by autosomal recessive loss-of-function mutations in the NGLY1 gene. NGLY1 removes N-linked glycans from glycoproteins in the cytoplasm and is thought to help clear misfolded proteins from the endoplasmic reticulum (ER) through the ER...
Saved in:
| Main Authors: | Travis K Tu'ifua, Clement Y Chow |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-08-01
|
| Series: | PLoS Genetics |
| Online Access: | https://doi.org/10.1371/journal.pgen.1011823 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preclinical pharmacology and safety studies to support an AAV9 NGLY1 gene therapy clinical trial for the treatment of NGLY1 deficiency
by: Lei Zhu, et al.
Published: (2025-09-01) -
Inhibition of proteasome rescues a pathogenic variant of respiratory chain assembly factor COA7
by: Karthik Mohanraj, et al.
Published: (2019-03-01) -
The Ubiquitin-Proteasome System in Huntington’s Disease: Are Proteasomes Impaired, Initiators of Disease, or Coming to the Rescue?
by: Sabine Schipper-Krom, et al.
Published: (2012-01-01) -
Comparative proteomics of HepG2 cells reveals NGLY1 as an important regulator of ferroptosis resistance and iron uptake
by: Stuart Emmerson, et al.
Published: (2025-01-01) -
Antagonism of proteasome inhibitor-induced heme oxygenase-1 expression by PINK1 mutation.
by: Xiang-Jun Sheng, et al.
Published: (2017-01-01)